Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MRSOTSE:5619 40 Forward Dividend Yield % is 0.00% as of Aug. 30, 2026. GuruFocus rates TSE:5619 with a GF Score™ of 40/100 and a GF Value™ of 円668.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 284 Healthcare Providers & Services companies, MRSO ranks worse than 352112.32% on this metric.
As of today (2026-08-30), the Forward Annual Dividend Yield of MRSO is 0.00%.
As of today (2026-08-30), the Trailing Annual Dividend Yield of MRSO is 0.00%.
TSE:5619's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.4 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
TSE:5619 vs VEEV, BTSG, HQY: Forward Dividend Yield % Comparison
For the Health Information Services subindustry, MRSO's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MRSO Forward Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MRSO's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where MRSO's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
MRSO (TSE:5619) has a Forward Dividend Yield % of 0.00% as of Aug. 30, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on MRSO and its competitors. According to the industry distribution chart, MRSO ranks #999999 out of 284 companies in the Healthcare Providers & Services industry.
Is MRSO's Forward Dividend Yield % too high?
MRSO's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, MRSO ranks #999999 out of 284 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MRSO has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MRSO's Forward Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MRSO ranks #999999 out of 284 companies for Forward Dividend Yield %. This places MRSO in the lower half of its industry. The industry median Forward Dividend Yield % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.40, based on 284 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on MRSO and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRSO's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRSO stock overvalued right now?
Based on GuruFocus' analysis, MRSO (TSE:5619) is currently considered Significantly Overvalued. The stock's GF Value™ is 円668.03, compared to a current price of 円905.00 — trading 35.5% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. MRSO's overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For MRSO (TSE:5619), the current Forward Dividend Yield % is 0.00% as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MRSO (TSE:5619) Overvalued in 2026?
Based on GuruFocus' analysis, MRSO stock appears to be overvalued.
The current stock price of 円905.00 is trading 35.5% above its estimated GF Value™ of 円668.03.
GuruFocus considers MRSO to be Significantly Overvalued.
Key valuation signals for TSE:5619:
Forward Dividend Yield %: 0.00%
GF Value™: 円668.03 vs. price of 円905.00 (35.5% above fair value)
No single metric tells the full story. See the TSE:5619 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MRSO Inc operates a healthcare platform and provides vertical SaaS solutions for medical institutions, government entities, and corporations. The company offers a preventive medical platform that enables reservations for medical checkups and various cancer screenings. It also provides administrative DX services that support tasks carried out by local governments, including the acceptance of reservations for resident health checkups and vaccinations. These administrative DX services are used by local governments across regions with varying population sizes.
40GF Score
Get the complete analysis for TSE:5619
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:5619 has been successfully added to your 
